http://www.unboundmedicine.com/medline/ebm/research/oxaliplatinUnbound MEDLINE is a service provided by Unbound Medicine, Inc. that includes data and services from the U.S. National Library of Medicine's MEDLINE® and PubMed® databases.en-usUnbound Medicine, Inc.http://www.unboundmedicine.com/medline/ebm/record/19923997/full_citation/Double_primary_adenocarcinomas_of_the_jejunum_and_descending_colon_with_lung_metastases_presenting_rare_immunohistochemical_phenotypes:_a_case_report_Nozawa H, Yamada Y, Muto Y, et al. 
Double primary adenocarcinomas of the jejunum and descending colon with lung metastases presenting rare immunohistochemical phenotypes: a case report. [JOURNAL ARTICLE]
Eur J Gastroenterol Hepatol 2009 Nov 17.
Abstract | Full Citationhttp://www.unboundmedicine.com/medline/ebm/record/19923093/full_citation/[Therapeutic_effect_of_docetaxel_combined_with_oxaliplatin_for_treatment_of_recurrent_epithelial_ovarian_cancer_]Wang J, Han N, Wang HL, et al. 
[Therapeutic effect of docetaxel combined with oxaliplatin for treatment of recurrent epithelial ovarian cancer.] [JOURNAL ARTICLE]
Nan Fang Yi Ke Da Xue Xue Bao 2009 Nov 20; 29(11):2319-2320.
Abstract | Full Citationhttp://www.unboundmedicine.com/medline/ebm/record/19922644/full_citation/Oxaliplatin_induced_loss_of_phosphorylated_heavy_neurofilament_subunit_neuronal_immunoreactivity_in_rat_DRG_tissue_Jamieson SM, Subramaniam J, Liu JJ, et al. 
Oxaliplatin-induced loss of phosphorylated heavy neurofilament subunit neuronal immunoreactivity in rat DRG tissue. [JOURNAL ARTICLE]
Mol Pain 2009 Nov 18; 5(1):66.
Abstract | Full Citation | Find Related Articles http://www.unboundmedicine.com/medline/ebm/record/19922504/full_citation/Influence_of_GSTP1_I105V_polymorphism_on_cumulative_neuropathy_and_outcome_of_FOLFOX_4_treatment_in_Asian_patients_with_colorectal_carcinoma_Chen YC, Tzeng CH, Chen PM, et al. 
Influence of GSTP1 I105V polymorphism on cumulative neuropathy and outcome of FOLFOX-4 treatment in Asian patients with colorectal carcinoma. [JOURNAL ARTICLE]
Cancer Sci 2009 Oct 28.
Abstract | Full Citation | Find Related Articles http://www.unboundmedicine.com/medline/ebm/record/19920832/full_citation/Quality_of_life_findings_from_a_randomised_phase_III_study_of_XELOX_vs_FOLFOX_6_in_metastatic_colorectal_cancer_Conroy T, Hebbar M, Bennouna J, et al. 
Quality-of-life findings from a randomised phase-III study of XELOX vs FOLFOX-6 in metastatic colorectal cancer. [JOURNAL ARTICLE]
Br J Cancer 2009 Nov 17.
Abstract | Full Citationhttp://www.unboundmedicine.com/medline/ebm/record/19919086/full_citation/Novel_Bis_platinum_Complexes_Endowed_with_an_Improved_Pharmacological_Profile_Gatti L, Perego P, Leone R, et al. 
Novel Bis-platinum Complexes Endowed with an Improved Pharmacological Profile. [JOURNAL ARTICLE]
Mol Pharm 2009 Nov 17.
Abstract | Full Citation | Find Related Articles http://www.unboundmedicine.com/medline/ebm/record/19917537/full_citation/Biomarkers_and_anti_EGFR_therapies_for_KRAS_wild_type_metastatic_colorectal_cancer_García-Sáenz JA, Sastre J, Díaz-Rubio García E 
Biomarkers and anti-EGFR therapies for KRAS wild-type metastatic colorectal cancer. [Journal Article]
Clin Transl Oncol 2009 Nov; 11(11):737-47.
Abstract | Full Citationhttp://www.unboundmedicine.com/medline/ebm/record/19915942/full_citation/Implications_of_KRAS_mutation_status_for_the_treatment_of_metastatic_colorectal_cancer_Ciardiello F, Tejpar S, Papamichael D 
Implications of KRAS mutation status for the treatment of metastatic colorectal cancer. [JOURNAL ARTICLE]
Target Oncol 2009 Nov 14.
Abstract | Full Citationhttp://www.unboundmedicine.com/medline/ebm/record/19904267/full_citation/Gemcitabine_oxaliplatin_and_5_FU_in_advanced_bile_duct_and_gallbladder_carcinoma:_two_parallel_multicentre_phase_II_trials_Wagner AD, Buechner-Steudel P, Moehler M, et al. 
Gemcitabine, oxaliplatin and 5-FU in advanced bile duct and gallbladder carcinoma: two parallel, multicentre phase-II trials. [JOURNAL ARTICLE]
Br J Cancer 2009 Nov 10.
Abstract | Full Citationhttp://www.unboundmedicine.com/medline/ebm/record/19894733/full_citation/Cytotoxic_Effects_of_Cardiac_Glycosides_in_Colon_Cancer_Cells_Alone_and_in_Combination_with_Standard_Chemotherapeutic_Drugs_Felth J, Rickardson L, Rosén J, et al. 
Cytotoxic Effects of Cardiac Glycosides in Colon Cancer Cells, Alone and in Combination with Standard Chemotherapeutic Drugs. [JOURNAL ARTICLE]
J Nat Prod 2009 Nov 6.
Abstract | Full Citation | Find Related Articles